This article was originally published by STAT on October 1, 2018. During my 19 years as a research scientist at the Upjohn Company, the regulatory burden imposed by the open-ended Drug Amendments Act of 1962 was mushrooming. My coworkers and I joked that because of this dramatic change to the mission of the FDA, made largely […]
The post A 1962 law slowed drug development. Changing it could slash drug prices appeared first on Official Site of Dr. Mary Ruwart.